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Human demodicosis: revisit and reclassiﬁcation
This review paper by Chen and Plewig revisits that old 
chestnut of human Demodex mites (Demodex folliculorum 
and Demodex brevis) and their possible role in skin disease. 
The authors contend that human demodicosis is a skin dis-
ease sui generis that can mimic other inﬂammatory derma-
toses such as folliculitis, rosacea and perioral dermatitis. 
They state that this has resulted in non-speciﬁc and con-
fusing descriptions in the literature. The authors propose 
classifying human demodicosis into a primary form and 
also a secondary form associated with iatrogenic immuno-
suppression. They describe primary demodicosis with the 
following four main clinical variants: (i) demodicosis spi-
nulosa, currently known as pityriasis folliculorum, involv-
ing sebaceous hair follicles without visible inﬂammation; 
(ii) demodicosis papulopustulosa, nod-ulocystica or con-
globata, with increasingly stronger inﬂammation leading 
to papules/pustules (Demodex folliculitis), nodules/cysts 
or abscesses, respectively; (iii) demodicosis blepharum, 
inducing chronic blepharitis or less commonly keratocon-
junctivitis; and (iv) demodicosis auris, causing otitis exter-
na or myringitis. Concerning treatment, they state that it is 
only weakly evidence based, and that the most effective 
concentrations of arachnicides remain to be determined. 
Br J Dermatol 2014; 170: 1219–1225.
Predicting pressure ulcers in  
hospitalized patients
This paper by Petzold et al. explores the possibility of 
predicting which inpatients will develop pressure ulcers. 
They explain that the prevention of pressure ulcers during 
inpatient treatment is an important public health issue, and 
highlight that predictors of incident pressure ulcers in hos-
pitalized patients, and the performance of existing pressure 
ulcer risk assessment instruments, are unclear. To address 
this problem, they have carried out a large prospective 
cohort study, which has identiﬁed higher age, female sex, 
length of hospitalization, treatment on an intensive care 
unit and admission from a care facility as independent pre-
dictors for incident pressure ulcers in hospitalized patients. 
They also assessed the performance of the Braden scale 
to assess individual pressure ulcer risk, and found differ-
ences in usage between normal care and intensive care 
units, with better performance on normal care units. Br J 
Dermatol 2014; 170: 1285–1290.
Mortality of bullous pemphigoid  
in Singapore
This study by Cai et al. reports on mortality due to bullous 
pemphigoid (BP) in Singapore. The authors start by explain-
ing that BP is the most common autoimmune-mediated 
subepidermal blistering skin disease, and is associated 
with signiﬁcant morbidity and mortality. The aim of their 
study was to determine the 3-year mortality rate, risk fac-
tors and causes of death in patients with BP in Singapore, 
compared with the general population. Using a retrospec-
tive cohort study of all newly diagnosed patients with BP 
seen at the National Skin Centre over a 6-year period, 
demographic and clinical data on comorbidities and treat-
ment were recorded. Mortality information was obtained 
from the National Registry of Diseases. In total 359 patients 
were included in the study. The authors concluded that 
this study conﬁrmed an increased 3-year mortality rate for 
patients with BP in Singapore. Treatment with combination 
therapy appeared to decrease mortality risk, even in elderly 
patients. Br J Dermatol 2014; 170: 1319–1326.
Laser-assisted drug delivery
This paper by Lim et al. from Korea starts by explaining that 
ablative fractional lasers can create microthermal channels 
that can facilitate the penetration of photosensitizers in pho-
todynamic therapy (PDT). The authors state that nonablative 
fractional lasers have minimal side-effects compared with 
ablative lasers. Their study demonstrated that nonablative 
fractional lasers can be used as pretreatment to enhance skin 
penetration of 5-ami-nolaevulinic acid (ALA) in PDT, with 
minimal skin disruption. They conclude that pretreatment 
with a nonablative fractional laser can be used for ALA-PDT 
to achieve higher therapeutic efficacy and shortened ALA 
incubation times. Br J Dermatol 2014; 170: 1336–1340.
